AI assistant
MPS Limited — Call Transcript 2026
Feb 9, 2026
62623_rns_2026-02-10_772ba0fc-f92d-4f8e-a52c-b25676b6a9be.pdf
Call Transcript
Open in viewerOpens in your device viewer
==> picture [318 x 38] intentionally omitted <==
Ref: MPSL/SE/111/2025-26 Date: 09 February 2026
National Stock Exchange of India Limited BSE Limited Exchange Plaza, 5th Floor, Plot no. C/1, Department of Corporate Services G Block, Bandra – Kurla Complex, Bandra (East), Phiroze Jeejeebhoy Towers Mumbai – 400 051, India Dalal Street, Mumbai- 400 001, India Symbol: MPSLTD Scrip Code: 532440 ISIN: INE943D01017 ISIN: INE943D01017
Dear Sirs,
Sub: Schedule of Conference Call on the Acquisition of Unbound Medicine, Inc., USA.
Pursuant to the Regulation 30 read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Company is organising a Conference Call scheduled as below:
==> picture [442 x 26] intentionally omitted <==
----- Start of picture text ----- Type of Meeting Day, Date and TimeConference Call on the acquisition of Unbound Wednesday,----- End of picture text -----
| Type of MeetingConference Call on the acquisition of Unbound | Day, Date and TimeWednesday, |
|---|---|
| Medicine, Inc., USA by MPS North America LLC, a | 18 February 2026, |
| wholly-owned subsidiary of the Company | 07:00 P.M. (IST) |
The Conference Call Invite for the above conference is enclosed herewith.
The same is also available on the Company's website at www.mpslimited.com under the head Investors.
This is for your kind information and record.
Thanking you,
Yours Faithfully, For MPS Limited
Raman Digitally signed by Raman Sapra Date: 2026.02.09 Sapra 23:53:03 +05'30' Raman Sapra Company Secretary & Compliance Officer
Encl: As above
Registered Office: RR Towers IV, Super A, 16/17, Thiru-Vi-Ka Industrial Estate, Guindy, Chennai-600032-India, Tel: +91 44 49162222 Email: [email protected] Corporate Identification Number: L22122TN1970PLC005795
==> picture [337 x 41] intentionally omitted <==
Invites you to the Conference Call on the Acquisition of Unbound Medicine, Inc., USA Scheduled on Date: Wednesday, 18 February 2026
Time: 07:00 P.M. (IST)
Participants:
Mr. Rahul Arora-Chairman and CEO, along with the senior management team of the Company will be present to address the call
Universal Dial In Numbers:* +91 22 6280 1410 +91 22 7115 8311
You may join through following link alternatively with Diamond Pass - No Wait Time https://services.choruscall.in/DiamondPassRegistration/register?confirmationNumber=47451 49&linkSecurityString=2665dbaff7
India National Toll Free 1 800 120 1221 International Toll Free Numbers USA: 18667462133 UK: 08081011573 Singapore: 8001012045 Hong Kong: 800964448 Australia: 0080014243444 China: 4008428405 Germany: 0080014243444
*When using dial-in numbers mentioned above, please do so 10 minutes prior to the call scheduled to ensure that you are connected to your call in time.
If Invitees may need any assistance during the conference call, please signal an operator by pressing “*” then “0” on your touch tone phone. Invitees who wishes to ask a question may press * and 1 on their touch-tone telephone.
For more information, please log on to www.mpslimited.com or contact: Investor Relations Desk
MPS Limited
Email: [email protected]
www.mpslimited.com
Registered Office: RR Towers IV, Super A, 16/17, Thiru-Vi-Ka Industrial Estate, Guindy, Chennai-600032-India, Tel: +91 44 49162222 Email: [email protected] Corporate Identification Number: L22122TN1970PLC005795